Accountable Care, Transparency and Data Management Punctuate Recent Healthcare Transactions

Accountable Care, Transparency and Data Management Punctuate Recent Healthcare Transactions

<0> TripleTreeJaimie Farel, 952-223-8400 </0>

TripleTree has announced three recent client deals cutting across the key healthcare areas of data integrity and analytics, transparency and consumer engagement, and accountable care. Collectively, these emerging growth companies - Enclarity, ZeOmega, and Change Healthcare - showcase innovations in technology that are improving the healthcare system in a reform-driven industry.

Recent research from TripleTree on healthcare consumerism and ACOs underpins some of the massive disruption occurring in the industry, and we look forward to working with best-in-class companies at the center of this transformation.

Triple Tree, LLC acted as the exclusive financial advisor to Enclarity, ZeOmega, and Change Healthcare.

TripleTree is an independent merchant bank focused on mergers and acquisitions, financial restructuring, and principal investing services. For more information, visit .

Enclarity solves healthcare's provider information problem with the largest and most accurate medical provider database. For more information, visit .

ZeOmega’s population health management platform delivers high-value, strategic solutions enabling payers and care-delivery organizations to improve individual health and provider performance. For more information, visit .

Change Healthcare is on a mission to transform the way Americans purchase and utilize healthcare services by driving sustainable engagement at the individual level. For more information, visit .

Suggested Articles

The profit margins and management of Community Health Group raise questions about oversight of managed care insurers.

Financial experts are warning practices about the pitfalls of promoting medical credit cards to their patients.

A proposed rule issued by HHS on Tuesday would expand short-term coverage, a move Seema Verma said will have "virtually no impact" on ACA premiums.